Comprehensive interventions for reducing cannabis use
                    
                    
                    Por:
                    Tirado-Munoz, J, Mestre-Pinto, JI, Farre, M, Fonseca, F and Torrens, M
                    
                     
                    Publicada:
                    1 jun 2018
                    
                    
                    
                    
                    
                        Categoría:
                        Psychiatry and mental health
                         
                     
                    
                     
                    
                        Resumen:
                         
                        Purpose of reviewCannabis is globally the most commonly cultivated, trafficked and consumed illicit drug of abuse. The current article provides an updated overview of existing comprehensive interventions for preventing and reducing cannabis use.Recent findingsThe PubMed database was searched for evidence regarding comprehensive interventions for preventing and reducing cannabis use from June 2016 to January 2018. The search resulted in 274 articles. Twenty-one studies were selected for assessment and 13 fulfilled the inclusion criteria. Six systematic reviews regarding preventive, psychosocial, pharmacological and risk reduction interventions were identified. Psychosocial interventions included therapist-assisted and computerized interventions. Four therapist-assisted, one computerized and two pharmacological clinical trials were published over the review period. Overall, considering the three different approaches (preventive, psychosocial or pharmacological) promising results have been found in certain interventions in reducing cannabis use among different types of users. In addition, recommendations to reduce adverse health outcomes related to cannabis use have also been reviewed.SummaryAlthough relevant findings have been found so far, further research with adequately powered trials assessing comprehensive interventions for reducing cannabis use remains a need before definitive treatment recommendations can be established.
                         
                     
                    
                         
                    
                    Filiaciones:
                    
                            
                            
                            Tirado-Munoz, J:
                               IMIM Inst Hosp del Mar Invest Med, Addict Res Grp, DoctorAiguader 88, Barcelona 08003, Spain 
                        
                            
                            Mestre-Pinto, JI:
                               IMIM Inst Hosp del Mar Invest Med, Addict Res Grp, DoctorAiguader 88, Barcelona 08003, Spain
   Univ Pompeu Fabra, Barcelona, Spain 
                        
                            
                            :
                               Hosp Univ Germans Trias & Pujol IGTP, Clin Pharmacol Dept, Badalona, Spain
   Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain 
                        
                            
                            Fonseca, F:
                               IMIM Inst Hosp del Mar Invest Med, Addict Res Grp, DoctorAiguader 88, Barcelona 08003, Spain
   Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain
   Hosp del Mar, Inst Neuropsiquiatria & Addicc, Barcelona, Spain
   IMIM Inst Hosp del Mar Invest Med, Barcelona, Spain 
                        
                            
                            Torrens, M:
                               IMIM Inst Hosp del Mar Invest Med, Addict Res Grp, DoctorAiguader 88, Barcelona 08003, Spain
   Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain
   Hosp del Mar, Inst Neuropsiquiatria & Addicc, Barcelona, Spain
   IMIM Inst Hosp del Mar Invest Med, Barcelona, Spain 
                        
                        
                    
                    
                        
                     
                 
                
                
             |